Effect of medication nonadherence in diabetes mellitus

Cardiology Review

Volumn 24, Issue 4, 2007, Pages 18-21

  Ho, P Michael ^a,b   Rumsfeld, John S ^a,b   Masoudi, Frederick A ^b,c   McClure, David L ^d   Plomondon, Mary E ^a   Steiner, John F ^b   Magid, David J ^b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d Clinical Research Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRESCRIPTION; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 34047198878     PISSN: 10926607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(1):S4-S36.
2. Saddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565-574.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
4. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
5. Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800-2805.
6. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
7. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15 (1 July), doi:10.1136/bmj.38875.675486.55 (published 21 June 2006).
8. Kogut SJ, Andrade SE, Willey C, et al. Nonadherence as a predictor of antidiabetic drug therapy intensification. Pharmacoepidemiol Drug Safety. 2004;13(9):591-598.
9. Krousel-Wood M, Thomas S, Munter P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357-362.
10. Miller NH, Hill M, Kottke, et al. The multilevel compliance challenge: recommendations for a call to action. Circulation. 1997;95(4):1085-1900.